SG11202011240YA - Crispr/cas and transposase based amplification compositions, systems and methods - Google Patents
Crispr/cas and transposase based amplification compositions, systems and methodsInfo
- Publication number
- SG11202011240YA SG11202011240YA SG11202011240YA SG11202011240YA SG11202011240YA SG 11202011240Y A SG11202011240Y A SG 11202011240YA SG 11202011240Y A SG11202011240Y A SG 11202011240YA SG 11202011240Y A SG11202011240Y A SG 11202011240YA SG 11202011240Y A SG11202011240Y A SG 11202011240YA
- Authority
- SG
- Singapore
- Prior art keywords
- crispr
- cas
- systems
- methods
- based amplification
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6813—Hybridisation assays
- C12Q1/6816—Hybridisation assays characterised by the detection means
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/10—Type of nucleic acid
- C12N2310/20—Type of nucleic acid involving clustered regularly interspaced short palindromic repeats [CRISPRs]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2527/00—Reactions demanding special reaction conditions
- C12Q2527/101—Temperature
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2527/00—Reactions demanding special reaction conditions
- C12Q2527/125—Specific component of sample, medium or buffer
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2531/00—Reactions of nucleic acids characterised by
- C12Q2531/10—Reactions of nucleic acids characterised by the purpose being amplify/increase the copy number of target nucleic acid
- C12Q2531/113—PCR
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/13—Plant traits
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y207/00—Transferases transferring phosphorus-containing groups (2.7)
- C12Y207/07—Nucleotidyltransferases (2.7.7)
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862690160P | 2018-06-26 | 2018-06-26 | |
| US201862767077P | 2018-11-14 | 2018-11-14 | |
| PCT/US2019/039195 WO2020006049A1 (en) | 2018-06-26 | 2019-06-26 | Crispr/cas and transposase based amplification compositions, systems and methods |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG11202011240YA true SG11202011240YA (en) | 2020-12-30 |
Family
ID=67263112
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG11202011240YA SG11202011240YA (en) | 2018-06-26 | 2019-06-26 | Crispr/cas and transposase based amplification compositions, systems and methods |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20210147915A1 (es) |
| EP (1) | EP3814519A1 (es) |
| JP (1) | JP2021528975A (es) |
| KR (1) | KR20210024009A (es) |
| CN (1) | CN112368396A (es) |
| AU (1) | AU2019294690A1 (es) |
| BR (1) | BR112020025319A2 (es) |
| CA (1) | CA3101066A1 (es) |
| MX (1) | MX2020013778A (es) |
| SG (1) | SG11202011240YA (es) |
| WO (1) | WO2020006049A1 (es) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20220097875A (ko) | 2019-09-03 | 2022-07-08 | 마이얼로이드 테라퓨틱스, 인크. | 게놈 통합을 위한 방법 및 조성물 |
| CA3210883A1 (en) * | 2021-02-09 | 2022-08-18 | Sherlock Biosciences, Inc. | Nucleic acid amplification using promoter primers |
| US11814689B2 (en) | 2021-07-21 | 2023-11-14 | Montana State University | Nucleic acid detection using type III CRISPR complex |
| KR102576803B1 (ko) * | 2022-10-14 | 2023-09-12 | 주식회사 풀무원 | CRISPR-Cas 기반의 리스테리아 모노사이토제네스 검출용 조성물 및 이를 이용한 리스테리아 모노사이토제네스 검출방법 |
Family Cites Families (38)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3494997B1 (en) | 2012-07-25 | 2019-09-18 | The Broad Institute, Inc. | Inducible dna binding proteins and genome perturbation tools and applications thereof |
| EP4234696A3 (en) | 2012-12-12 | 2023-09-06 | The Broad Institute Inc. | Crispr-cas component systems, methods and compositions for sequence manipulation |
| EP2931892B1 (en) | 2012-12-12 | 2018-09-12 | The Broad Institute, Inc. | Methods, models, systems, and apparatus for identifying target sequences for cas enzymes or crispr-cas systems for target sequences and conveying results thereof |
| US8697359B1 (en) | 2012-12-12 | 2014-04-15 | The Broad Institute, Inc. | CRISPR-Cas systems and methods for altering expression of gene products |
| IL300461A (en) | 2012-12-12 | 2023-04-01 | Harvard College | Engineering and optimization of improved systems, methods and enzyme compositions for sequence manipulation |
| WO2014093701A1 (en) | 2012-12-12 | 2014-06-19 | The Broad Institute, Inc. | Functional genomics using crispr-cas systems, compositions, methods, knock out libraries and applications thereof |
| US20140310830A1 (en) | 2012-12-12 | 2014-10-16 | Feng Zhang | CRISPR-Cas Nickase Systems, Methods And Compositions For Sequence Manipulation in Eukaryotes |
| PL2931898T3 (pl) | 2012-12-12 | 2016-09-30 | Le Cong | Projektowanie i optymalizacja systemów, sposoby i kompozycje do manipulacji sekwencją z domenami funkcjonalnymi |
| DK2931897T3 (en) | 2012-12-12 | 2018-02-05 | Broad Inst Inc | CONSTRUCTION, MODIFICATION AND OPTIMIZATION OF SYSTEMS, PROCEDURES AND COMPOSITIONS FOR SEQUENCE MANIPULATION AND THERAPEUTICAL APPLICATIONS |
| IL239344B1 (en) | 2012-12-12 | 2024-02-01 | Broad Inst Inc | Systems engineering, methods and optimal guiding components for sequence manipulation |
| EP2784162B1 (en) | 2012-12-12 | 2015-04-08 | The Broad Institute, Inc. | Engineering of systems, methods and optimized guide compositions for sequence manipulation |
| US11332719B2 (en) | 2013-03-15 | 2022-05-17 | The Broad Institute, Inc. | Recombinant virus and preparations thereof |
| KR20160030187A (ko) | 2013-06-17 | 2016-03-16 | 더 브로드 인스티튜트, 인코퍼레이티드 | 간의 표적화 및 치료를 위한 ＣＲＩＳＰＲＣａｓ 시스템, 벡터 및 조성물의 전달 및 용도 |
| SG11201510327TA (en) | 2013-06-17 | 2016-01-28 | Broad Inst Inc | Delivery, engineering and optimization of systems, methods and compositions for targeting and modeling diseases and disorders of post mitotic cells |
| WO2014204724A1 (en) | 2013-06-17 | 2014-12-24 | The Broad Institute Inc. | Delivery, engineering and optimization of tandem guide systems, methods and compositions for sequence manipulation |
| EP3011034B1 (en) | 2013-06-17 | 2019-08-07 | The Broad Institute, Inc. | Delivery, use and therapeutic applications of the crispr-cas systems and compositions for targeting disorders and diseases using viral components |
| EP3011033B1 (en) | 2013-06-17 | 2020-02-19 | The Broad Institute, Inc. | Functional genomics using crispr-cas systems, compositions methods, screens and applications thereof |
| AU2014281027A1 (en) | 2013-06-17 | 2016-01-28 | Massachusetts Institute Of Technology | Optimized CRISPR-Cas double nickase systems, methods and compositions for sequence manipulation |
| EP3011035B1 (en) | 2013-06-17 | 2020-05-13 | The Broad Institute, Inc. | Assay for quantitative evaluation of target site cleavage by one or more crispr-cas guide sequences |
| WO2015058052A1 (en) | 2013-10-18 | 2015-04-23 | The Broad Institute Inc. | Spatial and cellular mapping of biomolecules in situ by high-throughput sequencing |
| AU2014346559B2 (en) | 2013-11-07 | 2020-07-09 | Editas Medicine,Inc. | CRISPR-related methods and compositions with governing gRNAs |
| CA2932439A1 (en) | 2013-12-12 | 2015-06-18 | The Broad Institute, Inc. | Crispr-cas systems and methods for altering expression of gene products, structural information and inducible modular cas enzymes |
| EP4219699A1 (en) | 2013-12-12 | 2023-08-02 | The Broad Institute, Inc. | Engineering of systems, methods and optimized guide compositions with new architectures for sequence manipulation |
| CA2932475A1 (en) | 2013-12-12 | 2015-06-18 | The Broad Institute, Inc. | Delivery, use and therapeutic applications of the crispr-cas systems and compositions for targeting disorders and diseases using particle delivery components |
| EP3079725B1 (en) | 2013-12-12 | 2019-10-16 | The Broad Institute, Inc. | Delivery, use and therapeutic applications of the crispr-cas systems and compositions for genome editing |
| RU2016128077A (ru) | 2013-12-12 | 2018-12-06 | Те Брод Инститьют Инк. | Доставка, применение и применения в терапии систем и композиций crispr-cas для лечения обусловленных hbv и вирусных заболеваний и нарушений |
| BR112016013520A2 (pt) | 2013-12-12 | 2017-10-03 | Broad Inst Inc | Composições e métodos de uso de sistemas crispr-cas em distúrbios de repetições de nucleotídeos |
| WO2015089364A1 (en) | 2013-12-12 | 2015-06-18 | The Broad Institute Inc. | Crystal structure of a crispr-cas system, and uses thereof |
| JP6793547B2 (ja) | 2013-12-12 | 2020-12-02 | ザ・ブロード・インスティテュート・インコーポレイテッド | 最適化機能ＣＲＩＳＰＲ−Ｃａｓ系による配列操作のための系、方法および組成物 |
| EP3230452A1 (en) | 2014-12-12 | 2017-10-18 | The Broad Institute Inc. | Dead guides for crispr transcription factors |
| WO2016094874A1 (en) | 2014-12-12 | 2016-06-16 | The Broad Institute Inc. | Escorted and functionalized guides for crispr-cas systems |
| WO2016094867A1 (en) | 2014-12-12 | 2016-06-16 | The Broad Institute Inc. | Protected guide rnas (pgrnas) |
| CA2970370A1 (en) | 2014-12-24 | 2016-06-30 | Massachusetts Institute Of Technology | Crispr having or associated with destabilization domains |
| JP2018527947A (ja) * | 2015-07-17 | 2018-09-27 | プレジデント アンド フェローズ オブ ハーバード カレッジ | 核酸配列増幅方法 |
| WO2017189308A1 (en) * | 2016-04-19 | 2017-11-02 | The Broad Institute Inc. | Novel crispr enzymes and systems |
| CN105861552B (zh) * | 2016-04-25 | 2019-10-11 | 西北农林科技大学 | 一种T7 RNA聚合酶介导的CRISPR/Cas9基因编辑系统的构建方法 |
| PT3551753T (pt) | 2016-12-09 | 2022-09-02 | Harvard College | Diagnósticos baseados num sistema efetor de crispr |
| JP2020513815A (ja) | 2017-03-15 | 2020-05-21 | ザ・ブロード・インスティテュート・インコーポレイテッド | クラスター化短鎖反復回文配列エフェクター系に基づくウイルス検出用診断法 |
-
2019
- 2019-06-26 KR KR1020217001470A patent/KR20210024009A/ko not_active Application Discontinuation
- 2019-06-26 SG SG11202011240YA patent/SG11202011240YA/en unknown
- 2019-06-26 CA CA3101066A patent/CA3101066A1/en active Pending
- 2019-06-26 AU AU2019294690A patent/AU2019294690A1/en active Pending
- 2019-06-26 CN CN201980043102.2A patent/CN112368396A/zh active Pending
- 2019-06-26 WO PCT/US2019/039195 patent/WO2020006049A1/en active Application Filing
- 2019-06-26 JP JP2020572532A patent/JP2021528975A/ja active Pending
- 2019-06-26 US US17/054,428 patent/US20210147915A1/en active Pending
- 2019-06-26 BR BR112020025319-7A patent/BR112020025319A2/pt unknown
- 2019-06-26 MX MX2020013778A patent/MX2020013778A/es unknown
- 2019-06-26 EP EP19739830.8A patent/EP3814519A1/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| CN112368396A (zh) | 2021-02-12 |
| JP2021528975A (ja) | 2021-10-28 |
| KR20210024009A (ko) | 2021-03-04 |
| CA3101066A1 (en) | 2020-01-02 |
| US20210147915A1 (en) | 2021-05-20 |
| BR112020025319A2 (pt) | 2021-03-09 |
| MX2020013778A (es) | 2021-05-27 |
| EP3814519A1 (en) | 2021-05-05 |
| WO2020006049A1 (en) | 2020-01-02 |
| AU2019294690A1 (en) | 2020-12-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP3645054A4 (en) | COMPOSITIONS BASED ON CRISPR / CAS-ADENIN-DEAMINASE, SYSTEMS AND METHODS FOR TARGETED NUCLEIC ACID EDITING | |
| IL281159A (en) | New CRISPR enzymes and systems | |
| IL282746A (en) | Enzyme and a new CRISPR/CAS12F system | |
| SG11202106263XA (en) | Amplification methods and systems for merfish and other applications | |
| EP3500677A4 (en) | UNIQUE GUIDE RNA, CRISPR / CAS9 SYSTEMS AND METHODS OF USE | |
| EP3545085A4 (en) | CRISPR / CPF1 SYSTEMS AND METHODS | |
| EP3692145A4 (en) | NUCLEIC ACID TARGETED EDITING SYSTEMS, METHODS AND COMPOSITIONS | |
| EP3684397A4 (en) | SYSTEMS, METHODS AND COMPOSITIONS FOR TARGETED EDITION OF NUCLEIC ACIDS | |
| EP3701025A4 (en) | SYSTEMS, PROCEDURES AND COMPOSITIONS FOR TARGETED NUCLEIC ACID EDITING | |
| EP3727469A4 (en) | NEW CRISPR ENZYMES AND SYSTEMS | |
| EP3595694A4 (en) | CONSTRUCTION OF CAS9 CRISPR IMMUNE FURTIF | |
| EP3701042A4 (en) | SYSTEMS, PROCEDURES AND COMPOSITIONS FOR TARGETED NUCLEIC ACID EDITING | |
| EP3622062A4 (en) | DIRECTED EDITING OF CELLULAR RNA BY NUCLEAR ADMINISTRATION OF CRISPR / CAS9 | |
| EP3500671A4 (en) | NEW CRISPR ENZYMS AND SYSTEMS | |
| EP3500670A4 (en) | NEW CRISPR SYSTEMS AND ENZYMES | |
| SG10202010311SA (en) | Novel Crispr Enzymes and Systems | |
| EP3691747A4 (en) | RNA COMPOSITIONS AND EDITING PROCEDURES | |
| EP3823673A4 (en) | ANTI-CD112R COMPOSITIONS AND METHODS | |
| SG11202011240YA (en) | Crispr/cas and transposase based amplification compositions, systems and methods | |
| EP3334823A4 (en) | METHOD AND COMPOSITIONS FOR GENERATING CRISPR / CAS GUIDE RNA | |
| AU2018295992A1 (en) | Target-specific CRISPR mutant | |
| EP3715461A4 (en) | GENOMIC EDITION COMPOSITION USING A CRISPR / CPF1 SYSTEM AND ITS USE | |
| EP3337327A4 (en) | COMPOSITIONS OF NON-TOXIC PLANT AGENTS AND METHODS AND USES THEREOF | |
| IL278963A (en) | Dual NICKASE-based CRISPR amplification preparations, systems and methods | |
| WO2017214240A3 (en) | Cleaning compositions having an enzyme system |